FTSE 100
|
9 213,98
|
-36,45
|
-0,39 %
|
Analysen zu FTSE 100-Werten
| 10.01.24 | GSK Buy | Deutsche Bank AG | |
| 10.01.24 | Rolls-Royce Buy | UBS AG | |
| 10.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell Outperform | RBC Capital Markets | |
| 08.01.24 | easyJet Buy | UBS AG | |
| 08.01.24 | International Consolidated Airlines Neutral | UBS AG | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell Overweight | Barclays Capital | |
| 08.01.24 | Rolls-Royce Overweight | Barclays Capital | |
| 08.01.24 | Shell Buy | UBS AG | |
| 08.01.24 | RELX Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 05.01.24 | International Consolidated Airlines Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | Shell Overweight | Barclays Capital | |
| 04.01.24 | RELX Buy | UBS AG | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell Outperform | RBC Capital Markets | |
| 03.01.24 | easyJet Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | International Consolidated Airlines Outperform | Bernstein Research | |
| 03.01.24 | easyJet Market-Perform | Bernstein Research | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.12.23 | Unilever Market-Perform | Bernstein Research | |
| 28.12.23 | Reckitt Benckiser Outperform | Bernstein Research | |
| 27.12.23 | GSK Equal Weight | Barclays Capital | |
| 27.12.23 | AstraZeneca Buy | UBS AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.